Ticker

Analyst Price Targets — CPSH

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
November 13, 2025 9:30 amRoth Capital$6.00$3.30TheFly CPS Technologies initiated with a Buy at Roth Capital

Latest News for CPSH

Purepoint Uranium Reports 73,100 CPS Peak within 17,700 CPS Average over 1.8 Metres at Nova Discovery

Toronto, Ontario--(Newsfile Corp. - April 14, 2026) - Purepoint Uranium Group Inc. (TSXV: PTU) (OTCQB: PTUUF) ("Purepoint") reports that the nine holes of its winter 2026 drill program at the Nova Discovery have been successful in extending the uranium mineralization and favourable geology at the Dorado Joint Venture Project ("Dorado" or the "Project"), located in Saskatchewan's Athabasca Basin. Purepoint, as…

Newsfile Corp • Apr 14, 2026
CPS Announces Credit Facility Capacity Increase

LAS VEGAS, Nevada, April 06, 2026 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced that on April 3, 2026, it amended its two-year revolving credit agreement with Capital One, N.A. to increase the capacity of the facility.

GlobeNewsWire • Apr 6, 2026
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Paclitaxel ± Bevacizumab for the Treatment of Adults With PD-L1 (CPS ≥1) Platinum-Resistant Recurrent Ovarian Carcinoma Who Have Received One or Two Prior Systemic Treatment Regimens

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that KEYTRUDA® (pembrolizumab), in combination with paclitaxel, with or without bevacizumab, is approved in the European Union (EU) for the treatment of platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal carcinoma in adults whose tumors express PD-L1 with a Combined…

Business Wire • Apr 2, 2026
Critical Survey: ABCO Energy (OTCMKTS:ABCE) versus CPS Technologies (NASDAQ:CPSH)

ABCO Energy (OTCMKTS:ABCE - Get Free Report) and CPS Technologies (NASDAQ: CPSH - Get Free Report) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk and valuation. Institutional and Insider Ownership 11.2% of

Defense World • Mar 26, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for CPSH.

No House trades found for CPSH.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top